Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV
Despite its effectiveness in controlling plasma viremia, antiretroviral therapy (ART) cannot target proviral DNA, which remains an obstacle to HIV-1 eradication. When treatment is interrupted, the reservoirs can act as a source of viral rebound, highlighting the value of proviral DNA as an additiona...
Saved in:
| Main Authors: | Roberta Campagna, Chiara Nonne, Guido Antonelli, Ombretta Turriziani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/11/1697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units
by: Andrea De Vito, et al.
Published: (2025-05-01) -
Design and Characterization of Inhibitors of Cell-Mediated Degradation of APOBEC3G That Decrease HIV-1 Infectivity
by: Aubrey M. Sawyer, et al.
Published: (2025-04-01) -
Deletion, insertion and stop codon mutations in vif genes of HIV-1 infecting slow progressor patients
by: Héctor Rafael Rangel, et al.
Published: (2009-08-01) -
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy
by: Jenna M. Hasson, et al.
Published: (2025-07-01) -
Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection
by: Imane Belbacha, et al.
Published: (2024-05-01)